Sandra Misale Profile Banner
Sandra Misale Profile
Sandra Misale

@Sandra_Misale

Followers
3,494
Following
1,288
Media
37
Statuses
422

Assistant professor at Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

Baltimore, MD
Joined February 2012
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@Sandra_Misale
Sandra Misale
1 year
I have some news, I'm thrilled to announce that the Misale Lab will open in July at @hopkinskimmel @HopkinsMedicine ! We will work on resistance to therapy in solid tumors and we are hiring. Join us in this journey! #newPI #LabLaunch #cancer #kras #targetedtherapies #WomenInSTEM
60
57
405
@Sandra_Misale
Sandra Misale
5 months
Un emozionante weekend a Milano (bellissima). Grazie @chetempochefa @RobertoBurioni @fabfazio , mi avete dato la bellissima opportunità di raccontare un po di quello che faccio ogni giorno. Celebriamo le piccole vittorie e prepariamoci per le prossime sfide!
@chetempochefa
Che Tempo Che Fa
5 months
"10 anni fa è avvenuta la rivoluzione. C'è stata la prima forma di questo farmaco" @Sandra_Misale , Assistant Professor alla Johns Hopkins University di Baltimora dove ha fondato il Misale Lab, a #CTCF
15
59
581
70
110
1K
@Sandra_Misale
Sandra Misale
10 months
Proud to be among the 12 early-career investigators selected by @NatureCancer for“The 2023 Generation Viewpoint”, a nice perspective on challenges and opportunities about being a new PI. Please read and share! @HopkinsMedicine @hopkinskimmel @KRASKickers
33
28
363
@Sandra_Misale
Sandra Misale
2 years
Out today in @CD_AACR our new work where we describe the genetic bases of acquired resistance to EGFR/KRAS G12C dual blockade in colorectal cancer. Here’s the link of the paper and a thread👇:
21
46
220
@Sandra_Misale
Sandra Misale
1 year
It's real
Tweet media one
Tweet media two
16
4
201
@Sandra_Misale
Sandra Misale
1 year
Ringrazio @PaoloBricco e il @sole24ore per la meravigliosa esperienza, insolita e graditissima
Tweet media one
5
9
156
@Sandra_Misale
Sandra Misale
4 years
What’s the difference between colon and lung? Not an easy question when it comes to #KRAS . Our work out today in @CD_AACR today describe a strategy to overcome resistance to KRAS G12C inhibition in CRC. @sloan_kettering @Albert0Bardelli @BardelliLab 👇👇👇
15
36
146
@Sandra_Misale
Sandra Misale
1 year
I'm honored to be here sharing our work on resistance to KRAS inhibition. This is really the best time to be working on this topic, the field is flourishing with great ideas and opportunities! Also, great way to celebrate my birthday 😊 @KRASKickers @Undruggable
@AndrewMWaters
Andrew Waters
1 year
@Sandra_Misale presenting exciting research describing the benefit of combining EGFRi + KRASi in CRC. #killkras @KRASKickers
Tweet media one
Tweet media two
0
2
13
7
5
80
@Sandra_Misale
Sandra Misale
1 year
Oggi in visita al @MDAndersonNews di Houston. Esattamente 9 anni fa, un medico di Houston ha salvato la vita di mia madre donandole il midollo osseo. Essere un donatore significa poter diventare la ragione della felicità di qualcuno, pensateci. @ADMOitaly #donatoridivita
0
8
77
@Sandra_Misale
Sandra Misale
11 months
Paolo is an amazing oncolgist and a bright physician scientist. Today, we celebrate his achievements! More to come 😉 Orgoglio Italiano (Napoletano!) Bravissimo Dr. Tarantino! @PTarantinoMD @AIOMtweet
Tweet media one
4
8
76
@Sandra_Misale
Sandra Misale
1 year
Two research technician positions are immediately available in my lab @HopkinsMedicine @hopkinskimmel . You will be working on KRAS targeting in solid cancer. If interested, please apply here:
2
29
70
@Sandra_Misale
Sandra Misale
2 years
Best way to start the day in lab! @KlempnerSam presenting how our work here impacts the clinic. Feeling very proud of being a little part of this! @RonaYaeger #ESMO22 #CRC
Tweet media one
0
9
69
@Sandra_Misale
Sandra Misale
2 years
Proud to present this amazing work showing how oncology builds on genetics and molecular mechanisms to cure cancer patients. Kudos to my co-editors and all the authors! @ILugowska @caliraf @HaanenJohn @myESMO #ESMO22
4
9
67
@Sandra_Misale
Sandra Misale
4 years
Our paper is officially out on this month's @CD_AACR issue! Looking forward to seeing these results translated to clinic! @ElizSMcKenna @Albert0Bardelli @sloan_kettering
@CD_AACR
Cancer Discovery
4 years
Tweet media one
0
10
17
3
15
67
@Sandra_Misale
Sandra Misale
3 months
This past week has been both intense and amazing. @KRASKickers event @hopkinskimmel and first anniversary of the Misale Lab with some great news and additions to the team. I’m grateful, proud and ready to keep up with the good work! @HopkinsMedicine
Tweet media one
Tweet media two
6
1
64
@Sandra_Misale
Sandra Misale
11 months
Proud to share our work today at the AIOM National Congress together with the amazing Italian oncology community! Fiera di condividere i nostri lavori al congresso nazionale AIOM. La comunita' oncologica italiana e' impressionante, sono fiera di essere qui! @AIOMtweet @SCinieri
@PTarantinoMD
Paolo Tarantino
11 months
Excellent talk by @Sandra_Misale at the 50th Italian congress of medical oncology (AIOM), highlighting the terrific work that has conducted to refine the targeting of KRAS mutant tumors, once considered undraggable. @AIOMtweet
Tweet media one
1
3
30
2
7
63
@Sandra_Misale
Sandra Misale
1 year
Looking forward to participating at the 5th RAS - Targeted Drug Development Summit, in Boston this September 26-28.
Tweet media one
2
8
59
@Sandra_Misale
Sandra Misale
4 months
I’m extremely excited to announce that on June 26th 2024 we will hold the @KRASKickers @ Johns Hopkins event! We will talk about our efforts to make KRAS mutant cancers curable! Please share and join!
Tweet media one
2
8
55
@Sandra_Misale
Sandra Misale
2 years
Nei giorni scorsi, molte persone hanno deciso di seguirmi su Twitter (GRAZIE!). Credo che il modo migliore per conoscerci un po meglio sia ascoltare questo (bellissimo) podcast. Spero di ricevere e leggere molti commenti e pareri a riguardo😉 @AlterThink_ @AurelianoStingi
@AlterThink_
AlterThink
2 years
Il cancro può farci meno paura solamente se proveremo a conoscerlo meglio e impareremo ad accettarlo come una parte della nostra esistenza. Noi abbiamo provato a farlo raccontandovelo in un podcast. Trovate “La Grande C” su tutte le principali piattaforme di streaming.
1
11
39
1
10
50
@Sandra_Misale
Sandra Misale
1 year
Amazing talk on brain tumor architecture by @MarioSuva at #EACR2023
Tweet media one
1
4
46
@Sandra_Misale
Sandra Misale
2 years
@RobertoBurioni @MSKCancerCenter Grazie davvero Professore, ci portiamo a casa questa piccola vittoria pensando gia' alla prossima partita 💪😊
0
0
44
@Sandra_Misale
Sandra Misale
3 years
Spotlight on #KRAS targeting! Happy to share this new piece written in collaboration with the @Boehringer team @norbertkraut1 @MarcoHHofmann @gerlach_d @CD_AACR
@gerlach_d
Daniel Gerlach
3 years
📢Expanding the reach of precision🎯oncology by drugging all #KRAS mutants - our new review is out in @CD_AACR . Thanks to @MarcoHHofmann , @gerlach_d , @Sandra_Misale , Mark, and @norbertkraut1 #First4Patients #TakingCancerOn
Tweet media one
6
33
101
0
12
40
@Sandra_Misale
Sandra Misale
4 years
Tweet media one
1
1
34
@Sandra_Misale
Sandra Misale
1 year
Spotted the conference location from the plane! Looking forward to attending #EACR23 in the beautiful Turin
Tweet media one
3
0
34
@Sandra_Misale
Sandra Misale
1 year
This is amazing!👇 I attended @Johanna_A_Joyce talk at #EACR2023 and it has been one of the best moments of the whole conference. As women in science, part of our mission is support women and their future, in science and education. Looking forward to doing my part #WomenInSTEM
@Johanna_A_Joyce
Johanna Joyce
1 year
Delighted to donate from the #Pezcoller #EACR Women in Cancer Research Award to support #CAMFED - this is a great organisation that funds girls' education in Africa: #genderequality #education #payitforward 😊
Tweet media one
5
11
140
1
0
32
@Sandra_Misale
Sandra Misale
6 months
I'm feeling very happy (and proud) for all of this! @RonaYaeger
@AACR
AACR
6 months
The KRASG12C inhibitor adagrasib, paired with the EGFR inhibitor cetuximab, benefited patients with metastatic colorectal cancer in the KRYSTAL-1 trial, presented by Scott Kopetz, MD, PhD and published in @CD_AACR . #AACR24 @skopetz @MDAndersonNews
Tweet media one
1
11
52
0
1
32
@Sandra_Misale
Sandra Misale
4 months
Doctor Curigliano @curijoey is among the best mentors I ever met and an amazing oncolgist, I would be proud to having him as the next ESMO president!
@curijoey
G Curigliano MD PhD
4 months
For 25 years, I've witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists. Their unwavering support and inspiration are the pillars of our future in oncology. Let's continue to empower their bright minds 🌟 #FutureLeaders #MentorshipMatters
7
22
86
1
5
32
@Sandra_Misale
Sandra Misale
2 years
@RobertoBurioni Grazie Prof. Burioni! lo scopo di questo manuale e' anche quello di arrivare agli oncologi a livello globale e "avvicinare" i grandi e i piccoli centri, per migliorare diagnosi e trattamenti per i pazienti oncologici. Le risorse non sono sempre cosi lontane se si conoscono :)
0
0
31
@Sandra_Misale
Sandra Misale
4 years
Opening for a Research Technician position in Rosen lab @sloan_kettering working with me! Looking for a highly motivated person who wants to learn about biochemistry, pharmacology and anticancer targeted therapies. Interested? Apply here: pls Retweet!
0
11
28
@Sandra_Misale
Sandra Misale
3 years
Proud of being part of an amazing journey to @Nature with @whitefishlab & @Joshua_M_Weiss !Anatomic position of tumor cells plays important role and the implications are several, including pharmacological targeting. Looking fwd to more understanding of the role of crkl in melanoma
@whitefishlab
richard white
3 years
A longstanding question in cancer: why do tumors only form in certain locations in the body? In our new @nature paper (), we define anatomic position of the cell as a mechanism for this.
63
485
2K
3
0
29
@Sandra_Misale
Sandra Misale
3 years
Last year we published the rationales to combine G12C inhibitors with anti-EGFR agents in colon cancer and the use of TDXd in HER2-mutant lung cancer. Very satisfying to see these results translated into clinical successes. #ESMO21
0
4
28
@Sandra_Misale
Sandra Misale
2 years
Non vedo l'ora! Grazie @AlterThink_ e @AurelianoStingi , mi sento onorata di esser parte di questo progetto 😊
@AlterThink_
AlterThink
2 years
ESISTERÀ MAI UNA CURA PER IL CANCRO? Ne parleremo a La Grande C con @Sandra_Misale , Senior Research Scientist al Memorial Sloan–Kettering Cancer Center, New York. Quali novità possiamo aspettarci dal punto di vista dei farmaci contro il cancro? @AurelianoStingi
Tweet media one
2
2
19
1
2
27
@Sandra_Misale
Sandra Misale
1 year
"Feeling grateful and excited for visiting @MDAndersonNews today. It's been 9years since a Houston doctor saved my mother's life by donating his bone marrow stem cells. Consider registering to be a donor, you can be the reason someone finds joy in their darkest hour. #DonateLife
0
1
27
@Sandra_Misale
Sandra Misale
2 years
In conclusion, we show that KRAS G12C amplification is a frequent mechanism of resistance to G12C-EGFR blockade. Acquisition of an oncogene-induced senescence in these cells can be exploited as a therapeutic opportunity using senolytic agents.
Tweet media one
1
3
25
@Sandra_Misale
Sandra Misale
1 year
@AmbrogioLab rocking at Ras symposium today #EACR2023
Tweet media one
0
7
24
@Sandra_Misale
Sandra Misale
2 years
Huge thanks and Kudos to all the authors and collaborators @RonaYaeger @Rosenlab1 @LoweLabMSKCC @r_mezzadra @DSolit @MFBerger1 @YoninaMG @Mirati @BoundlessBio 💪💪💪and @CD_AACR and Michele Hartsough for the amazing work together! Ad Maiora!
2
4
23
@Sandra_Misale
Sandra Misale
1 year
Look at this nice group of #KRASkickers ! It's always a privilege to see you Terri ❤️ We'll keep 🚫KRASholes together! @KRASKickers @AndrewMWaters @cjder23
Tweet media one
0
0
20
@Sandra_Misale
Sandra Misale
10 months
@RobertoBurioni @NatureCancer Grazie Professore! Siamo solo all'inizio ma e' bello avere supporto e incoraggiamento!
2
0
19
@Sandra_Misale
Sandra Misale
2 years
First, we modeled acquired resistance to EGFR-KRAS G12C inhibitors combination in preclinical systems: resistant models developed secondary RAS/RAF mutations and KRAS G12C amplifications, then we detected heterogeneous genetic alterations in CRC patients at clinical resistance.
Tweet media one
1
0
19
@Sandra_Misale
Sandra Misale
2 years
Sei curioso/a di sapere com'è fare scienza e di quali sono le opportunità in questo campo?Allora ci vediamo domani sera assieme a @FPFabrizioPhD su Pillole di Ricerca Scientifica, diretta instagram con @MariluCasini @marco_heffler !
@FPFabrizioPhD
Federico Pio Fabrizio
2 years
📌Domani ore 21 sulla mia pagina Instagram "Pillole di Ricerca Scientifica" sarò live con @Sandra_Misale @MariluCasini @marco_heffler per spiegare quello che accade nel mondo della ricerca ma anche per rispondere alle vostre domande/curiosità! A domani, vi aspettiamo!
Tweet media one
5
5
34
0
1
18
@Sandra_Misale
Sandra Misale
3 months
Today I had the honor to present our work @CampusClinicUB @UniBarcelona , meet amazing investigators, and touch base with a fantastic friend and colleague @JoanMonte . Plus, I got to see @barrigafm ! Outstanding scientific community here in Barcelona!
@JoanMonte
Joan Montero
3 months
Thank you @Sandra_Misale for visiting us @CampusClinicUB @UniBarcelona and for such an inspiring presentation! Your work will definitely help improve cancer treatment. And happy lab anniversary @hopkinskimmel !
Tweet media one
Tweet media two
1
1
9
2
0
17
@Sandra_Misale
Sandra Misale
4 years
Congratulations to @ScaltritiLab , @EmilianoCocco2 , @alexdrilon , @TheChandraGroup and @aventura71 ! Another Great story! Check it out!
0
3
15
@Sandra_Misale
Sandra Misale
10 months
Don't miss @RonaYaeger editorial on @NEJM !
@RonaYaeger
Rona Yaeger
10 months
Check out my editorial on the CodeBreaK 300 trial in @NEJM . At clinical doses, current KRAS G12C inhibitors are at the edge of the threshold for response in CRC so that response rates meaningfully shift with more potent drugs or higher doses of drug.
1
12
80
0
2
16
@Sandra_Misale
Sandra Misale
5 years
Great journey and great ending, can't wait to expand to other #HER2 amplified/mutant cancer types! @ScaltritiLab @FlaviaMichelini @sloan_kettering @CD_AACR
@ScaltritiLab
Maurizio Scaltriti
5 years
Here’s our new work on HER2 ADCs in ERBB2 amplified or mutant lung cancer out in @CD_AACR . Great team effort with Bob Li, @FlaviaMichelini , @Sandra_Misale and many others at @sloan_kettering . Below a thread: @DanaFarber
5
33
92
3
3
14
@Sandra_Misale
Sandra Misale
2 years
Upon drug withdrawal, tumor cells with acquired KRAS G12C amplification showed hyper activation of MAPK and mTOR pathways and acquired an oncogene-induced senescence(IOS)phenotype (thanks @LoweLabMSKCC @r_mezzadra and Almudena Chaves Perez. This was further confirmed in a patient
Tweet media one
1
0
15
@Sandra_Misale
Sandra Misale
2 years
The allele frequency of KRAS G12C amplification diminished overtime upon treatment stop, possibly due to IOS. While intermittent re-challenge with the same therapy does not overcome resistance, treatment with the dual mTOR inhibitor AZD8055 is effective in this setting.
Tweet media one
1
0
14
@Sandra_Misale
Sandra Misale
1 year
@Johanna_A_Joyce
Johanna Joyce
1 year
Two great talks this morning at #EACR2023 by two incredible scientists - Direna Alonso-Curbelo and Anna Obenauf giving the @EMBO_YIP lecture 🤩👏 @DirenaAC @obenaufa @IRBBarcelona @IMPvienna
Tweet media one
Tweet media two
0
6
94
0
0
13
@Sandra_Misale
Sandra Misale
2 years
We then analyzed the heterogeneity of genetic resistance mechanisms overtime: most of these genetic alterations do not increase together with tumor markers, except for KRAS G12C amplification.
Tweet media one
1
0
13
@Sandra_Misale
Sandra Misale
2 years
@FPFabrizioPhD Grazie mille Federico!ti seguo da tempo e sono felicissima di leggere questo tuo commento
1
0
13
@Sandra_Misale
Sandra Misale
2 years
This is amazing!
@Winkler_Lab
The Winkler Lab
2 years
Can we decode the language of brain tumor network communication, and what this means for malignancy? Here we show that some glioblastoma cells activate the rest in a pacemaker-like manner. We are excited to share our work now online @Nature : . A 🧵👇
47
280
1K
0
3
11
@Sandra_Misale
Sandra Misale
5 months
@GiacomoGorini Grazie Giacomo!! Andiamo avanti, piano piano si fa tutto!💪
0
0
12
@Sandra_Misale
Sandra Misale
3 years
Looking forward to watching this
@AstraZeneca
AstraZeneca
3 years
Watch the official trailer for a documentary celebrating the life and legacy of José Baselga – father, husband, colleague, mentor and #cancer ’s fiercest opponent. Premiering March 2022.
0
30
110
0
0
12
@Sandra_Misale
Sandra Misale
4 years
KRAS G12C mutant #organoids and patients-derived xenografts show response to this combination, with complete tumor regression in vivo #CRC #KRAS #sciencetwitter
Tweet media one
1
1
11
@Sandra_Misale
Sandra Misale
4 years
We need to take care of this
@PTarantinoMD
Paolo Tarantino
4 years
Very important topic addressed by this recent @NatRevClinOncol perspective ⚠️ A pandemic of early onset CRC (<50 y) is affecting the world, w/ dramatic consequences 👉Reasons still remain speculative 👉we REALLY NEED to understand (& stop) all this
Tweet media one
2
5
15
0
2
9
@Sandra_Misale
Sandra Misale
5 months
0
0
8
@Sandra_Misale
Sandra Misale
5 years
Am I watching? a: Moon landing b: Colorectal cancer cell line #nerdy #science #lablife #colorectalcancer #targetedtherapy @sloan_kettering
4
0
8
@Sandra_Misale
Sandra Misale
4 years
@ElizSMcKenna
Elizabeth McKenna
4 years
Check out this tweetorial on the latest @CD_AACR paper @Sandra_Misale , @Albert0Bardelli @BardelliLab on what underlies resistance to #KRAS G12C inhibition in #colorectalcancer - very relevant for upcoming #ASCO20 discussions!
0
2
22
0
0
8
@Sandra_Misale
Sandra Misale
5 years
When your sister works on Ras and you didn't know it..! Proud of you little sister, should we start collaborating now?😁
@ClaudiaMisale
Claudia Misale
5 years
Proud to be part of the team!
0
0
9
0
0
7
@Sandra_Misale
Sandra Misale
5 years
Hi Twitter community!Please support our team "The Guns and Rosens" for @Cycle4Survival @Sloan_Kettering . Every donation to our ride will help make a difference!
1
0
7
@Sandra_Misale
Sandra Misale
4 years
Combinatorial approach using #AMG510 and #Cetuximab induces cell proliferation arrest and #apoptosis
Tweet media one
1
0
7
@Sandra_Misale
Sandra Misale
5 years
Dear Friends, the south of #Italy is less affected by #COVID19 for now. However, we dont have enough hospitals in the south and if #CoronavirusOutbreak will hit harder, it will be catastrophic. Please consider to donate here, help preventing this to happen
0
0
6
@Sandra_Misale
Sandra Misale
1 year
@AurelianoStingi Caro! Enjoy!! :) <3 Per chi volesse leggerlo lo trova sul sito di ESMO ed e' gratis per i membri
2
0
5
@Sandra_Misale
Sandra Misale
5 years
I'm so proud to advertise my best friend Matteo @LabLigorio , he's a great person and he's going to make great science, so postdoc applicants please consider! @utswcancer #pancreaticcancer #cancerresearch #tumorheterogeneity
0
1
6
@Sandra_Misale
Sandra Misale
4 years
Molecular response to KRAS G12C inhibitors is different in CRC and NSCLC models. CRC models show quick MAPK pathway rebound
Tweet media one
1
0
6
@Sandra_Misale
Sandra Misale
5 years
Some numbers actually show that there's no time to give up, we have to give our best everyday and eventually it will become the best for real💪
0
0
5
@Sandra_Misale
Sandra Misale
4 years
Check this out!😉
@ElizSMcKenna
Elizabeth McKenna
4 years
Looking forward to back-to-back educational sessions on drug resistance at #AACR20 - "Novel Targeted Agents and Mechanisms of Resistance" followed by "Overcoming Therapeutic Resistance: Challenges and Opportunities" - Here are a few the most recent @CD_AACR papers on resistance:
1
6
20
0
1
5
@Sandra_Misale
Sandra Misale
2 years
@GabrielePicco2 @CD_AACR Grazie Gabriele! sono fortunata a lavorare con queste persone fantastiche :)
0
0
5
@Sandra_Misale
Sandra Misale
4 years
I'm currently on a H1B Visa, let's see if in November I have to swim back to Italy.. Scientists: Support for the innovation engine of American science: via @Change
0
0
5
@Sandra_Misale
Sandra Misale
9 months
@panagis21 Same here🤣❤️ snowman building is also on the activities menu for today, together with Zoom meetings and grant writing
0
0
3
@Sandra_Misale
Sandra Misale
2 years
@Massi_Fantini84 @FPFabrizioPhD Non è sempre un argomento semplice da affrontare, molte persone hanno paura di fare prevenzione e spero che si arrivi a superare questi timori. Grazie @Massi_Fantini84 per il tuo impegno, se posso aiutare fammelo sapere!
0
0
5
@Sandra_Misale
Sandra Misale
1 year
@fbranda94 Grazie Francesco, la Calabria c'è! 💪
0
0
5
@Sandra_Misale
Sandra Misale
1 year
@ElizSMcKenna Starting @hopkinskimmel in a few weeks, can't wait ! #newPI
1
0
5
@Sandra_Misale
Sandra Misale
5 months
@kimgordon222 @chetempochefa È esatto, non sono associato😊 spero di diventarlo presto anche se adesso il focus principale è di gettare nuove basi per gli studi correnti e per quelli futuri. La progressione di carriera arriverà a tempo debito. Intanto vi ringrazio tutti tantissimo!
0
0
5
@Sandra_Misale
Sandra Misale
5 years
"The continuous decline in the cancer mortality rate since 1991 has resulted in an overall drop of 29%, translating into approximately 2.9 million fewer cancer deaths." Work in progress, but it really looks good so far!💪 #cancerresearch #cancerprevention
1
1
5
@Sandra_Misale
Sandra Misale
6 years
#7Book challenge: day 6. Nominations tomorrow 😊
Tweet media one
0
1
4
@Sandra_Misale
Sandra Misale
2 years
Missing to be there in person😊 @myESMO
@ONCOassist
ONCOassist® | The go-to oncology app
2 years
A splendid start to #ESMO22 . Let's take a look at the top influencers on day 1. #OncoAlert #MedTwitter #OncTwitter #OncEd
Tweet media one
0
1
7
0
0
4
@Sandra_Misale
Sandra Misale
4 years
@CDebyaniPhD @LesokhinMD It looks like we were all there today!!sharing your feelings though😊
0
0
4
@Sandra_Misale
Sandra Misale
1 year
@pills_ofscience @AurelianoStingi Siete troppo buoni, grazie!❤️
2
0
3
@Sandra_Misale
Sandra Misale
1 year
@gerlach_d
Daniel Gerlach
1 year
Great to see our work on the SOS1-KRAS inhibitor BI-3406, published in @CD_AACR in January 2021, to be listed among the top 5 most-cited articles from 2021-2022:
0
2
14
0
0
4
@Sandra_Misale
Sandra Misale
1 year
🤣
@Rafabolism
Arafath (Rafa) Najumudeen
1 year
HRAS, KRAS and NRAS @KRASKickers
Tweet media one
1
3
12
0
0
4
@Sandra_Misale
Sandra Misale
2 years
@AurelianoStingi Grazie Aureliano!
0
0
4
@Sandra_Misale
Sandra Misale
4 years
Receptor tyrosine kinases and EGFR dependency is stronger in CRC models
Tweet media one
1
0
3
@Sandra_Misale
Sandra Misale
4 years
@FilippoPietran4 Ti porto io in Calabria!😍
1
0
3
@Sandra_Misale
Sandra Misale
8 months
@PTarantinoMD @raffcolo Repeat after me: target expression≠response 🤣
0
0
3
@Sandra_Misale
Sandra Misale
1 year
1
0
2
@Sandra_Misale
Sandra Misale
1 year
🤩
@Aiims1742
Anirban Maitra
1 year
Spectacular talk by @FertigLab at #AACRPan23 on leveraging spatial transcriptomics data in #PancreaticCancer precursors using computational network analyses. Great example of interdisciplinary science between @lauradelongwood @ltkagohara @JZimmermanMDPhD @GenesOfEve et al….
Tweet media one
Tweet media two
3
17
111
1
0
3
@Sandra_Misale
Sandra Misale
5 years
Liquid biopsy on another level! Check this work from Dr. Siravegna!😉 @GiugiSira
0
0
3